Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China

Virology Journal

Volumn 8, Issue , 2011, Pages

  Wang, Hui ^a   Liu, Jian ^a   Dilimulati, ^a   Li, Liang ^a   Ren, Zhihui ^a   Wen, Hao ^a   Wang, Xing ^a,b  

^a First Teaching Hospital   (Taiwan)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Kaposi's sarcoma (KS); Kaposi's sarcoma associated herpesvirus (KSHV); risk factors; seroprevalence; Uygur people; Xinjiang

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DILUTION; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FEMALE; HERPES VIRUS INFECTION; HUMAN; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK FACTOR; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHINA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES;

HUMAN HERPESVIRUS 8;

EID: 84863050465     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-539     Document Type: Article

References (35)

1. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Simonart Thierry, Cancer Letters 2006 244 1 7 10.1016/j.canlet.2006.02.005 16542773 (Pubitemid 44485873)
2. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Chang Y, Cesarman E, Pessin MS, et al. Science 1994 266 1865 1869 10.1126/science.7997879 7997879
3. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Schalling M, Ekman M, Kaaya EE, et al. Nat Med 1995 1 707 708 10.1038/nm0795-707 7585156
4. Transmission of human herpesvirus 8 by blood transfusion. Hladik W, Dollard SC, Mermin J, et al. N Engl J Med 2006 355 1331 1338 10.1056/NEJMoa055009 17005950 (Pubitemid 44465461)
5. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Beral V, Peterman TA, Berkelman RL, et al. Lancet 1990 335 123 128 10.1016/0140-6736(90)90001-L 1967430 (Pubitemid 20032724)
6. Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients. Giovanni S, Antonio S, Barbara I, et al. N Engl J Med 2005 352 1317 1323 10.1056/NEJMoa042831 15800227 (Pubitemid 40411498)
7. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Gao SJ, Kingsley L, Li M, et al. Nat Med 1996 2 925 928 10.1038/nm0896-925 8705864 (Pubitemid 26296765)
8. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Whitby D, Howard MR, Tenant-Flowers M, et al. Lancet 1995 346 799 802 10.1016/S0140- 6736(95)91619-9 7674745
9. Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users. Zavitsanou A, Malloiri M, Sypsa V, et al. Epidemiol Infect 2010 138 403 408 10.1017/S0950268809990628 19698211
10. Kaposi's Sarcoma-associated Herpesvirus(KSHV/HHV8): Key Aspects of Epidemiology and Pathogenesis. Abel VB, Thomas FS., AIDS Rev 2003 5 222 229 15012001
11. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Boshoff C, Schulz TF, Kennedy MM, et al. Nat Med 1995 1 1274 1278 10.1038/nm1295-1274 7489408
12. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. Staskus KA, Zhong W, Gebhard K, et al. J Virol 1997 71 715 719 8985403 (Pubitemid 26412345)
13. Kaposi's sarcoma-associated herpesviurs infection prior to onset of Kaposi's sarcoma. Moore PS, Kingsley LA, Holmberg SD, et al. AIDS 1996 10 175 180 10.1097/00002030-199602000-00007 8838705 (Pubitemid 26056010)
14. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. Kedes DH, Ganem D, Ameli N, et al. JAMA 1997 277 478 481 10.1001/jama.1997.03540300046032 9020272 (Pubitemid 27074332)
15. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Rezza G, Lennette ET, Giuliani M, et al. Intl J Cancer 1998 77 361 365 10.1002/(SICI)1097-0215(19980729)77:3<361::AID- IJC9>3.0.CO;2-M (Pubitemid 28299870)
16. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Gao SJ, Kingsley L, Li M, et al. Nat Med 1996 2 925 928 10.1038/nm0896-925 8705864 (Pubitemid 26296765)
17. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Boshoff C, Weiss RA, Phil Trans R Soc Lon Biol Sci 2001 356 517 534 10.1098/rstb.2000.0778 (Pubitemid 32442750)
18. Seroprevalence of Kaposi's Sarcoma-associated Herpesvirus and Risk Factors in Xinjiang, China. Fu B, Sun F, Li B, et al. J Med Virol 2009 81 1422 1431 10.1002/jmv.21550 19551832
19. Seroprevalence of Kapsosi's sarcom-associated herpesvirus in the central population from Hubei provine. Fang Q, Liu J, Q BZ, et al. Viroligica Sinica 2006 21 97 101
20. Higher prevalence of human herpesvirus 8 DNA sequence and specific IgG antibodies in patients with pemphigus in China. Wang GQ, Xu H, Wang YK, et al. J Am Acad Dermatol 2005 52 460 467 10.1016/j.jaad.2004.10.882 15761424
21. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China. He F, Wang X, He B, et al. J Med Virol 2007 79 161 166 10.1002/jmv.20730 17177299 (Pubitemid 46048504)
22. Antibody to human herpesvirus type 8 in the general populations of Xinjiang Autonomous Region. Du W, Chen G, Sun H, et al. Chinese J Exp ClinVirol 2000 14 44 47
23. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Wang X, He B, Zhang ZX, et al. Virology Journal 2010 7 62 69 10.1186/1743-422X-7-62 20236530
24. Antibodies against human herpesvirus 8 in black South African patients with cancer. Sitas F, Carrara H, Beral V, et al. N Engl J Med 1999 340 1863 1871 10.1056/NEJM199906173402403 10369849 (Pubitemid 29272666)
25. Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas. Baillargeon J, Deng JH, Hettler E, et al. Ann Epidemiol 2001 11 512 518 10.1016/S1047-2797(01)00242-3 11557184 (Pubitemid 32824116)
26. Kaposi's sarcoma in South Africa. Sitas F, Newton R, J Nati Cancer Inst Monogr 2001 28 1 4
27. Antibodies against human herpesvirus 8 in South African renal transplant recipients and blood donors. Stein L, Carrara H, Norman R, et al. Transplant Infection Disease 2004 6 69 73 10.1111/j.1399-3062.2004.00061.x (Pubitemid 39540403)
28. Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: Seroprevalence and associated factors. Zavitsanou A, Sypsa V, Petrodaskalaki M, et al. J Med Virol 2007 79 591 596 10.1002/jmv.20812 17385692 (Pubitemid 46564358)
29. Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users. Zavitsanou A, Malliori M, Sypsa V, et al. Epidemiol Infect 2010 138 403 408 10.1017/S0950268809990628 19698211
30. Investigation on knowledge, attitude and behaviour regarding hypertension among the Kazakh residents in Xinjiang. Li N, GUO SX, Zhang YH, et al. Journal of Shihezi University 2007 25 203 206
31. Environmental factors influence the rate of human herpesvirus type 8 infection in a population with high incidence of classic Kaposi sarcoma. Angeloni A, Masala MV, Montesu MA, et al. Clin Infect Dis 2006 42 66 e68 10.1086/500397 16511749
32. Demographic indicators and risk of infection with human herpesvirus type 8 in central Italy. Valdarchi C, Serraino D, Cordiali Fei P, et al. Infection 2007 35 22 25 10.1007/s15010-007-5123-2 17297585 (Pubitemid 46295041)
33. Socio-Economic and Other Correlates of Kaposi Sarcoma-Associated Herpesvirus Seroprevalence Among Older Adults in Sicily. Pelser C, Vitale F, Whitby D, et al. J Med Virol 2009 81 1938 1944 10.1002/jmv.21589 19777527
34. Risk factors for high anti-HHV-8 antibody titers (1:51 200)in black HIV-1 negative South African cancer patients: a case control study. Wojcicki JM, Newton R, Urban MI, et al. BMC Infect Dis 2003 3 21 32 10.1186/1471-2334-3-21 12971827 (Pubitemid 38671449)
35. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. Mbulaiteye S, Atkinson J, Whitby D, et al. J Clin Virol 2006 35 442 449 10.1016/j.jcv.2005.10.010 16414306 (Pubitemid 43324843)